Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Wins $420,000 NCI Grant to Study Genetics of Colorectal Cancer with Johns Hopkins

NEW YORK, Feb. 23 (GenomeWeb News) - Perlegen Sciences has won a grant from the National Cancer Institute to study DNA mutations involved in colorectal cancer, in collaboration with researchers at Johns Hopkins University, the company said today.


The grant, worth $420,000 and awarded to Perlegen in fiscal year 2004, according to an NIH database, is entitled "Comprehensive Mutational Analysis of the Cancer Genome." Perlegen scientists, led by Andrew Sparks, the company's director of association studies, plan to analyze thousands of genes in colorectal tumor samples at single-base resolution and compare them to the same genes in normal tissue from the same patients. The aim is to find tumor-specific mutations.


Perlegen will work with scientists at the SidneyKimmelComprehensiveCancerCenterat Johns Hopkins for this project.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.